Cuba has accumulated 30, 023,092 million anti-COVID-19 doses administered with the national immunogens Soberana 02, Soberana Plus and Abdala by the end of December 26.

The province of Camaguey is included as of today in the Phase II clinical trial with the vaccine candidate Mambisa and the Abdala vaccine in COVID-19 convalescents, carried out at the Hermanos Ameijeiras Surgical Clinical Hospital in Havana.

Cuba studied a total of 15,544 samples for surveillance during the day, resulting positive 145. The country accumulates 11, 608,349 samples taken and 965,002 positive.

After having sent to Vietnam five million doses of Abdala vaccine, which now are being applied with very good results in the population and in view of the current outbreak of COVID-19, Cuba ratified its willingness to offer another similar amount for its application in pediatric ages once the Vietnamese regulatory entity issues the authorization for emergency use.

Cuba reported today 128 new COVID-19 cases, 63 medical discharges and one death.

Political and government authorities urged people to observe discipline in order to guarantee the levels of immunology achieved in this province, where more than 94% of the population has already completed some of the anti-COVID-19 vaccination scheme.

Cuba reported today 76 new COVID-19 cases, 62 medical discharges and zero deaths.

 Some 927 thousand 302 citizens have been administered a COVID-19 booster in Cuba with locally developed vaccines in order to be better protected against the virus.

 Cuba reported today 89 new COVID-19 cases, 91 medical discharges and zero deaths.

A nanobiomedical tool for the control of the COVID-19 pandemic is the first of four works competing for the National Awards of the Cuban Academy of Sciences of Sciences for scientific research results in 2021.

As part of the programs for the informatization of Cuban society, the public health sector in the province of Holguin is expanding the digitalization of the COVID-19 vaccination process, one of the steps involved in border control.

Over 9.5 million people in Cuba have already been immunized against COVID-19 with locally developed vaccines, standing for 85.1 percent of the over 11-million Cuban population.

Cuba reported today 80 new COVID-19 cases, 87 medical discharges and one fatality.

The Cuban Ministry of Public Health has decided to speed up the vaccination process with the COVID-19 booster, for which the national biopharmaceutical industry will deliver more than six million doses of the immunogens Abdala, Soberana 02 and Soberana Plus in the coming weeks.